COVID 19 Content: An AHA Compendium

The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.

Recently Added

Man in white coat holding sheet of brain scan imagesEarly Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients (Stroke, August 19)
The study authors "aimed to compare anterior circulation large vessel occlusion strokes severity between patients with and without COVID-19."

ST-Segment–Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub (Circulation: Cardiovascular Interventions, August 14)
"Aim of this study was to assess clinical features of patients with STEMI during COVID-19 pandemic."

Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care (Stroke, August 13)
"A streamlined poststroke treatment protocol was developed to limit frequency of patient encounters while maximizing the yield of each encounter by grouping together different components of poststroke care into single bedside visits."

Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering from Coronavirus Disease in Wuhan, China (JAHA, August 14)
"This study aimed to summarize the clinical characteristics and laboratory indicators of COVID‐19 patients with CVD, especially the critically ill patients."

Previous AHA Journal Science

All AHA Journal COVID-19 Content

Stroke and Brain Health

Latest Previous


HeartBEATS from Lifelong Learning, Science Series: COVID-19 Cardiovascular Syndrome (Paid, credit available)
Listen to a discussion on COVID-19 Syndrome and cardiac damage.

2020 AHA Western States COVID-19 Webinar Series: Strategic Ways To Navigate Stroke Care And COVID-19 (Free, credit available)
Understand the variety of clinical presentations, including cardiomyopathy, ventricular arrhythmias and hemodynamic instability in SARS-CoV-2 infection, and formulate appropriate treatment plans.

COVID-19 Ventilator Reskilling (Paid, certificate available)
This self-directed, adaptive eLearning course helps health care providers in the acute care setting improve knowledge and competence in mechanical ventilation skills.

Patient on Vent

Featured Videos

The Critical Role of Health Care Professionals During the COVID-19 Pandemic

Dr. Stephen Hahn, FDA Commissioner speaks with health care professionals about the FDA’s role in responding to the COVID-19 public health emergency, and the critical role of medical professionals as they face the challenges of COVID-19 response. Transcript of Dr. Hahn's August 10, 2020 remarks

COVID-19 and the Heart

Mina Chung, MD interviews Eduardo Marbán, MD, PhD about his invited lecture on "COVID and the Heart," which he presented Monday during BCVS 2020. Read Dr. Marban's April article in Circulation Research entitled "COVID-19 and the Heart."

COVID-19 and Venous Thromboembolism

Mina Chung, MD interviews Sanjum Sethi, MD, MPH about his BCVS 2020 invited lecture on "COVID-19 and Thromboembolism," which presents some of the lessons he learned from treating COVID-19 patients during the pandemic surge in New York.


Featured Podcast

COVID-19 and Thrombosis

Part of AHA's COVID-19 Clinical Guidance Podcast Series

This 25-minute discussion touches on the unique coagulopathy caused by the SARS-CoV-2 virus, along with diagnosis and thrombo-prophylaxis techniques and treatment options. Featuring Naomi Hamburg, MD, MS, FACC, Associate Professor of Medicine, Boston University; and Mary Cushman, MD, MSc, FAHA, Professor of Medicine, University of Vermont. Read a transcript here (PDF).

Other Podcasts

AHA Research Community

Lawrence Livermore National Labs/AHA COVID-19 Data Portal

This collaboration on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2.

This searchable data portal houses a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based "virtual" screening of interactions with SARS-CoV-2 viral proteins for drug design purposes.

Other Resources